These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 215175)

  • 1. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG; Orö L
    Atherosclerosis; 1982 Apr; 42(2-3):229-43. PubMed ID: 6951582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
    Carlson LA; Olsson G; Ballantyne D
    Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
    Mordasini R; Riesen W; Oster P; Keller M; Middelhoff G; Lang PD
    Atherosclerosis; 1981 Oct; 40(2):153-8. PubMed ID: 6796096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
    Föger B; Tröbinger G; Ritsch A; Lechleitner M; Hopferwieser T; Menzel HJ; Utermann G; Pfeiffer KP; Patsch JR
    Atherosclerosis; 1995 Oct; 117(2):253-61. PubMed ID: 8801871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
    Vessby B; Carlson LA
    Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
    Lehtonen A; Viikari J
    Atherosclerosis; 1979 May; 33(1):49-58. PubMed ID: 223601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
    Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA; Lang PD
    Atherosclerosis; 1977 Jul; 27(3):279-87. PubMed ID: 901625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
    Ballantyne D; Ballantyne FC; Stromberg P; Third JL; Bedford DK
    Clin Chim Acta; 1978 Feb; 83(1-2):117-22. PubMed ID: 202421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.
    Ballantyne D; Olsson AG; Carlson LA
    Atherosclerosis; 1978 May; 30(1):79-87. PubMed ID: 209798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.